BRETT MONIA

Corporate Board Profile

Tech Score: 50/100

Software Technology Evidence

1 mention(s) identify BRETT MONIA as having software/technology expertise.

Company	Filing Date	Evidence	Reason
IONIS PHARMACEUTICALS INC	2021-04-23	Dr. Monia was promoted to Chief Executive Officer in January 2020. From January 2018 to December 2019, Dr. Monia served as our Chief Operating Officer, from January 2012 to January 2018, as our Senior Vice President, Drug Discovery, from February 2009 to January 2012, as our Vice President, Drug Discovery, and from October 2000 to February 2009, as our Vice President, Preclinical Drug Discovery. From October 1989 to October 2000, he held various positions within our Molecular Pharmacology department. ... Dr. Monia is the inventor on over 100 issued patents and has directly supervised programs resulting in the clinical development of more than 40 antisense-based drugs across a broad range of therapeutic areas.	Dr. Monia has a Ph.D. and extensive experience in molecular pharmacology and drug discovery, including inventing over 100 patents and supervising programs for antisense-based drugs, indicating strong technical and scientific expertise likely including programming skills.

IONIS PHARMACEUTICALS INC

Filing Date	Source Excerpt
2019-04-26	Dr. Monia was promoted to Chief Operating Officer in January 2018. From January 2012 to January 2018, Dr. Monia served as our Senior Vice President, Drug Discovery, and from February 2009 to January 2012, he served as our Vice President, Drug Discovery.
2021-04-23	Dr. Monia was promoted to Chief Executive Officer in January 2020. From January 2018 to December 2019, Dr. Monia served as our Chief Operating Officer, from January 2012 to January 2018, as our Senior Vice President, Drug Discovery, from February 2009 to January 2012, as our Vice President, Drug Discovery, and from October 2000 to February 2009, as our Vice President, Preclinical Drug Discovery. From October 1989 to October 2000, he held various positions within our Molecular Pharmacology department. ... Dr. Monia is the inventor on over 100 issued patents and has directly supervised programs resulting in the clinical development of more than 40 antisense-based drugs across a broad range of therapeutic areas.

Filing Date

Source Excerpt

2019-04-26

Dr. Monia was promoted to Chief Operating Officer in January 2018. From January 2012 to January 2018, Dr. Monia served as our Senior Vice President, Drug Discovery, and from February 2009 to January 2012, he served as our Vice President, Drug Discovery.

2021-04-23

Dr. Monia was promoted to Chief Executive Officer in January 2020. From January 2018 to December 2019, Dr. Monia served as our Chief Operating Officer, from January 2012 to January 2018, as our Senior Vice President, Drug Discovery, from February 2009 to January 2012, as our Vice President, Drug Discovery, and from October 2000 to February 2009, as our Vice President, Preclinical Drug Discovery. From October 1989 to October 2000, he held various positions within our Molecular Pharmacology department. ... Dr. Monia is the inventor on over 100 issued patents and has directly supervised programs resulting in the clinical development of more than 40 antisense-based drugs across a broad range of therapeutic areas.

Data sourced from SEC filings. Last updated: 2025-08-30